Physician profile
Bobbita Nag
NPI 1013115369
$1,367.32
in general payments reported to CMS, 2019-2025
17 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $207 · 2021: $16.42 · 2023: $116 · 2024: $225 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $266.09 | 2019-2020 | |
| Tris Pharma INC | $234.80 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $129.02 | 2024 | Uzedy |
| Corium, LLC | $103.10 | 2023 | Azstarys |
| Tempus Ai, INC | $96.06 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $95.00 | 2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $94.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.84 | 2019-2020 | |
| Lundbeck LLC | $50.71 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $49.13 | 2019 | |
| Abbvie INC. | $29.73 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $29.31 | 2019-2025 | Spravato |
| Shire North American Group INC | $27.26 | 2019 | |
| Vertical Pharmaceuticals, LLC | $25.95 | 2019 | |
| Neurocrine Biosciences, INC. | $22.72 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $18.78 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobbita Nag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.